SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-008136
Filing Date
2021-01-13
Accepted
2021-01-13 16:07:22
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d11417d424b5.htm 424B5 517752
2 GRAPHIC g11417g38i90.jpg GRAPHIC 53235
3 GRAPHIC g11417g51x44.jpg GRAPHIC 96775
4 GRAPHIC g11417g70x59.jpg GRAPHIC 141678
  Complete submission text file 0001193125-21-008136.txt   920942
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-226266 | Film No.: 21526169
SIC: 2834 Pharmaceutical Preparations